Laboratory and clinical experience with oral pregneninolone

被引:6
作者
Cohen, MR [1 ]
Stein, IF [1 ]
机构
[1] Michael Reese Hosp, Res Dept, Samuel A Deutsch Serum Ctr, Dept Obstet & Gynecol, Chicago, IL USA
关键词
D O I
10.1016/S0002-9378(40)91263-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:713 / 724
页数:12
相关论文
共 13 条
[1]  
ASTWOOD E. B., 1939, JOUR ENDOCRINOL, V1, P49, DOI 10.1677/joe.0.0010049
[2]  
Clauberg C., 1938, ZBL GYN, V62, P1745
[3]  
Courrier R, 1939, CR SOC BIOL, V130, P1162
[4]   Multiple activities of anhydro-oxy-progesterone [J].
Emmens, CW ;
Parkes, AS .
NATURE, 1939, 143 :1064-1064
[5]  
EMMENS CW, 1939, J ENDOCRINOL, V1, P23
[6]   Progesterone is androgenic [J].
Greene, RR ;
Burrill, MW ;
Ivy, AC .
ENDOCRINOLOGY, 1939, 24 (03) :351-357
[7]   Oral use of pregneninonol in functional meno-metrorrhagia [J].
Hamblen, EC ;
Powell, NB ;
Cuyler, WK ;
Pattee, CT .
ENDOCRINOLOGY, 1940, 26 (02) :201-207
[8]  
HOHLWEG WALTER, 1939, KLIN WOCHENSCHR, V18, P77, DOI 10.1007/BF01773828
[9]   New per os-effective female hipofisis gland hormone derivatives: 17-aethinyl-oesteridol and pregnen-in-on-3-ol-17. [J].
Inhoffen, HH ;
Hohlweg, W .
NATURWISSENSCHAFTEN, 1938, 26 :96-96
[10]  
RUZICKA L, 1938, HELV CHIM ACTA, V21, P372